Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (3045)
Metagenomi Therapeutics, Inc. (MGX)
Reid Laurence — Director
Shares
117
Price
$1.18
Total Value
$138.06
Shares Held After
20,000
% of Holdings
0.6%
Metagenomi Therapeutics, Inc. (MGX)
Reid Laurence — Director
Shares
19,883
Price
$1.17
Total Value
$23.26K
Shares Held After
19,883
% of Holdings
100.0%
AN2 Therapeutics, Inc. (ANTX)
Readnour Robin Shane — Director
Shares
585
Price
$6.02
Total Value
$3.52K
Shares Held After
624,765
% of Holdings
0.1%
AN2 Therapeutics, Inc. (ANTX)
Readnour Robin Shane — Director
Shares
523
Price
$6.02
Total Value
$3.15K
Shares Held After
557,467
% of Holdings
0.1%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
572
Price
$68.67
Total Value
$39.28K
Shares Held After
1,326,594
% of Holdings
0.0%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
9,428
Price
$67.79
Total Value
$639.12K
Shares Held After
1,327,166
% of Holdings
0.7%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
160
Price
$542.55
Total Value
$86.81K
Shares Held After
202,967
% of Holdings
0.1%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
362
Price
$541.65
Total Value
$196.08K
Shares Held After
203,127
% of Holdings
0.2%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
505
Price
$540.19
Total Value
$272.80K
Shares Held After
203,489
% of Holdings
0.2%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
215
Price
$539.03
Total Value
$115.89K
Shares Held After
203,994
% of Holdings
0.1%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
520
Price
$538.30
Total Value
$279.91K
Shares Held After
204,209
% of Holdings
0.3%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
640
Price
$537.17
Total Value
$343.79K
Shares Held After
204,729
% of Holdings
0.3%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
1,040
Price
$536.11
Total Value
$557.56K
Shares Held After
205,369
% of Holdings
0.5%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
644
Price
$535.27
Total Value
$344.72K
Shares Held After
206,409
% of Holdings
0.3%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
396
Price
$534.20
Total Value
$211.54K
Shares Held After
207,053
% of Holdings
0.2%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
512
Price
$533.09
Total Value
$272.94K
Shares Held After
207,449
% of Holdings
0.2%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
368
Price
$531.99
Total Value
$195.77K
Shares Held After
207,961
% of Holdings
0.2%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
522
Price
$530.23
Total Value
$276.78K
Shares Held After
208,329
% of Holdings
0.2%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
347
Price
$529.27
Total Value
$183.66K
Shares Held After
208,851
% of Holdings
0.2%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
131
Price
$527.88
Total Value
$69.15K
Shares Held After
209,198
% of Holdings
0.1%
NovaBridge Biosciences (NBP)
Cao Sean Wuxiong — Chief Bus. Development Officer
Shares
107,978
Price
$0.74
Total Value
$79.90K
Shares Held After
266,467
% of Holdings
28.8%
Tyra Biosciences, Inc. (TYRA)
Verjee Rehan — Director
Shares
972
Price
$20.58
Total Value
$20.00K
Shares Held After
972
% of Holdings
100.0%
INSMED Inc (INSM)
Brennan David R — Director
Shares
25,000
Price
$124.00
Total Value
$3.10M
Shares Held After
39,238
% of Holdings
38.9%
Pharvaris N.V. (PHVS)
Glassman Robert — Director
Shares
8,000
Price
$37.55
Total Value
$300.40K
Shares Held After
10,500
% of Holdings
43.2%
RELMADA THERAPEUTICS, INC. (RLMD)
TRAVERSA SERGIO — Director
Shares
100,000
Price
$4.18
Total Value
$418.00K
Shares Held After
1,400,000
% of Holdings
7.1%
RELMADA THERAPEUTICS, INC. (RLMD)
Shenouda Maged — Chief Financial Officer
Shares
120,200
Price
$4.20
Total Value
$504.84K
Shares Held After
920,200
% of Holdings
13.1%
Protagonist Therapeutics, Inc (PTGX)
PATEL DINESH V PH D — Director
Shares
63,548
Price
$146.18
Total Value
$9.29M
Shares Held After
522,968
% of Holdings
10.8%
Inhibrx Biosciences, Inc. (INBX)
MANHARD KIMBERLY — Director
Shares
500
Price
$115.80
Total Value
$57.90K
Shares Held After
9,000
% of Holdings
5.3%
Fortrea Holdings Inc. (FTRE)
Russell Carrie Elizabeth — Interim CAO
Shares
246
Price
$16.85
Total Value
$4.15K
Shares Held After
2,384
% of Holdings
9.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$509.00
Total Value
$101.80K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
506
Price
$507.68
Total Value
$256.88K
Shares Held After
324,643
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
794
Price
$506.84
Total Value
$402.43K
Shares Held After
325,149
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
875
Price
$505.78
Total Value
$442.56K
Shares Held After
325,943
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
964
Price
$505.03
Total Value
$486.85K
Shares Held After
326,818
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,144
Price
$503.60
Total Value
$576.12K
Shares Held After
327,782
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,017
Price
$502.87
Total Value
$511.41K
Shares Held After
328,926
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
361
Price
$500.84
Total Value
$180.80K
Shares Held After
329,943
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
519
Price
$499.73
Total Value
$259.36K
Shares Held After
330,304
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$498.85
Total Value
$199.54K
Shares Held After
330,823
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$497.56
Total Value
$79.61K
Shares Held After
331,223
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,278
Price
$496.73
Total Value
$634.82K
Shares Held After
331,383
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,202
Price
$495.65
Total Value
$595.77K
Shares Held After
332,661
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$493.81
Total Value
$39.50K
Shares Held After
333,863
% of Holdings
0.0%
YD Bio Ltd (YDES)
Shen Ethan PhD — Director
Shares
3,100
Price
$3.93
Total Value
$12.18K
Shares Held After
11,245,631
% of Holdings
0.0%
Korro Bio, Inc. (KRRO)
Dolan Oliver — Senior Vice President, Finance
Shares
6
Price
$13.60
Total Value
$81.62
Shares Held After
16,246
% of Holdings
0.0%
Fortrea Holdings Inc. (FTRE)
Morais Mark A. — Chief Operating Officer
Shares
3,149
Price
$16.85
Total Value
$53.06K
Shares Held After
81,794
% of Holdings
3.7%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
5,836
Price
$2.09
Total Value
$12.20K
Shares Held After
2,775,229
% of Holdings
0.2%
Grace Therapeutics, Inc. (GRCE)
Kohli Prashant — Director
Shares
100,000
Price
$2.14
Total Value
$214.00K
Shares Held After
121,357
% of Holdings
82.4%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
3,097
Price
$68.70
Total Value
$212.78K
Shares Held After
536,876
% of Holdings
0.6%
Entrada Therapeutics, Inc. (TRDA)
MPM BioVentures 2014, L.P. — 10% Owner
Shares
28,837
Price
$7.13
Total Value
$205.61K
Shares Held After
3,885,115
% of Holdings
0.7%
Showing 401–450 of 3045 transactions (page 9 of 61)